Pharmanutra S.p.A.

BIT:PHN Voorraadrapport

Marktkapitalisatie: €516.9m

Pharmanutra Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Pharmanutra heeft een totaal eigen vermogen van €58.9M en een totale schuld van €24.5M, wat de schuld-eigenvermogensverhouding op 41.6% brengt. De totale activa en totale passiva bedragen respectievelijk €115.6M en €56.7M. De EBIT Pharmanutra is €26.9M waardoor de rentedekking 19.8 is. Het heeft contanten en kortetermijnbeleggingen van €17.8M.

Belangrijke informatie

41.6%

Verhouding schuld/eigen vermogen

€24.48m

Schuld

Rente dekkingsratio19.8x
Contant€17.82m
Aandelen€58.90m
Totaal verplichtingen€56.70m
Totaal activa€115.60m

Recente financiële gezondheidsupdates

Recent updates

Investors Interested In Pharmanutra S.p.A.'s (BIT:PHN) Earnings

Sep 11
Investors Interested In Pharmanutra S.p.A.'s (BIT:PHN) Earnings

Pharmanutra's (BIT:PHN) Shareholders Have More To Worry About Than Only Soft Earnings

Mar 23
Pharmanutra's (BIT:PHN) Shareholders Have More To Worry About Than Only Soft Earnings

Is Now The Time To Put Pharmanutra (BIT:PHN) On Your Watchlist?

Sep 26
Is Now The Time To Put Pharmanutra (BIT:PHN) On Your Watchlist?

These 4 Measures Indicate That Pharmanutra (BIT:PHN) Is Using Debt Safely

May 16
These 4 Measures Indicate That Pharmanutra (BIT:PHN) Is Using Debt Safely

Pharmanutra (BIT:PHN) Could Easily Take On More Debt

Jan 11
Pharmanutra (BIT:PHN) Could Easily Take On More Debt

Capital Allocation Trends At Pharmanutra (BIT:PHN) Aren't Ideal

Nov 02
Capital Allocation Trends At Pharmanutra (BIT:PHN) Aren't Ideal

Pharmanutra (BIT:PHN) Will Be Hoping To Turn Its Returns On Capital Around

Aug 03
Pharmanutra (BIT:PHN) Will Be Hoping To Turn Its Returns On Capital Around

Is Now The Time To Put Pharmanutra (BIT:PHN) On Your Watchlist?

May 20
Is Now The Time To Put Pharmanutra (BIT:PHN) On Your Watchlist?

Returns On Capital Signal Tricky Times Ahead For Pharmanutra (BIT:PHN)

Apr 19
Returns On Capital Signal Tricky Times Ahead For Pharmanutra (BIT:PHN)

Are Strong Financial Prospects The Force That Is Driving The Momentum In Pharmanutra S.p.A.'s BIT:PHN) Stock?

Mar 10
Are Strong Financial Prospects The Force That Is Driving The Momentum In Pharmanutra S.p.A.'s BIT:PHN) Stock?

Is There More To The Story Than Pharmanutra's (BIT:PHN) Earnings Growth?

Feb 17
Is There More To The Story Than Pharmanutra's (BIT:PHN) Earnings Growth?

Should You Be Adding Pharmanutra (BIT:PHN) To Your Watchlist Today?

Feb 01
Should You Be Adding Pharmanutra (BIT:PHN) To Your Watchlist Today?

Is Pharmanutra S.p.A. (BIT:PHN) A Smart Choice For Dividend Investors?

Jan 18
Is Pharmanutra S.p.A. (BIT:PHN) A Smart Choice For Dividend Investors?

Is Pharmanutra (BIT:PHN) A Risky Investment?

Jan 04
Is Pharmanutra (BIT:PHN) A Risky Investment?

Shareholders Of Pharmanutra (BIT:PHN) Must Be Happy With Their 220% Total Return

Dec 22
Shareholders Of Pharmanutra (BIT:PHN) Must Be Happy With Their 220% Total Return

Do Insiders Own Lots Of Shares In Pharmanutra S.p.A. (BIT:PHN)?

Dec 08
Do Insiders Own Lots Of Shares In Pharmanutra S.p.A. (BIT:PHN)?

Is Pharmanutra S.p.A.'s(BIT:PHN) Recent Stock Performance Tethered To Its Strong Fundamentals?

Nov 23
Is Pharmanutra S.p.A.'s(BIT:PHN) Recent Stock Performance Tethered To Its Strong Fundamentals?

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( €63.4M ) PHN } overtreffen de korte termijn passiva ( €28.1M ).

Langlopende schulden: De kortetermijnactiva PHN ( €63.4M ) overtreffen de langetermijnschulden ( €28.6M ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 11.3% ) PHN wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van PHN is de afgelopen 5 jaar gestegen van 19.2% naar 41.6%.

Schuldendekking: De schuld van PHN wordt goed gedekt door de operationele kasstroom ( 93.4% ).

Rentedekking: De rentebetalingen op de schuld van PHN worden goed gedekt door EBIT ( 19.8 x dekking).


Balans


Ontdek gezonde bedrijven